OLPAZA 150

Olpaza 150 Tablet is an ‘anti-cancer’ medication used to treat various types of cancer, including ovarian, breast, pancreatic, and prostate cancers. Cancer is a condition characterized by the uncontrolled growth and reproduction of cells in a specific area of the body. These cancerous cells can invade and damage surrounding healthy tissues, including organs.

Olpaza 150 Tablet contains Olaparib, a targeted therapy known as a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that assists in the repair of damaged cells. Olaparib inhibits the function of PARP. Certain cancer cells depend on PARP to maintain their DNA integrity. Therefore, when Olaparib halts PARP from repairing DNA damage, the cancer cells ultimately perish.

Administer this medication as prescribed by your healthcare provider. You may occasionally experience shortness of breath (dyspnea), fatigue, pale skin, rapid heartbeat, anemia, nausea, vomiting, indigestion or heartburn (dyspepsia), loss of appetite, headaches, altered taste (dysgeusia), dizziness, cough, and diarrhea. Most of these side effects may gradually diminish over time. However, if they persist or worsen, seek advice from your doctor.

To effectively manage your condition, continue taking Olpaza 150 Tablet for the duration prescribed by your doctor. Do not discontinue the use of Olpaza 150 Tablet  prematurely.